Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Alpha-1 antitrypsin (inhalation use)

EU orphan designation number: EU/3/04/243   
Active ingredient: Alpha-1 antitrypsin (inhalation use)
Indication: Treatment of cystic fibrosis
Sponsor: Triskel EU Services Ltd.
124 Baker Street, London W1U 6TY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/11/2004 Centralised Orphan - Designation EMEA/OD/053/04 (2004)4464 of 16/11/2004
13/07/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/04/T/01 (2007)3305 of 02/07/2007
11/12/2007 Other procedure
08/04/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/04/T/02 (2009)2732 of 03/04/2009
09/11/2010 Other procedure EMA/581017/2010
20/01/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/04/T/03 (2010)9545 of 17/12/2010
01/03/2011 Other procedure EMEA/OD/053/04
17/12/2012 Other procedure
29/07/2013 Centralised Orphan - Transfer of orphan designation EMEA/OD/053/04/T/04 (2013)4954 of 25/07/2013
23/01/2014 Centralised Orphan - Change of address